Yamaguchi Yuri, Takei Hiroyuki, Suemasu Kimito, Kobayashi Yasuhito, Kurosumi Masafumi, Harada Nobuhiro, Hayashi Shin-ichi
Research Institute for Clinical Oncology, Saitama Cancer Center, Japan.
Cancer Res. 2005 Jun 1;65(11):4653-62. doi: 10.1158/0008-5472.CAN-04-3236.
In postmenopausal breast cancers, locally produced estrogen by adipose stromal cells causes the progression of tumor growth. Although aromatase, a key enzyme of estrogen synthesis, is highly expressed in the adipose stromal cells, and aromatase inhibitors show greater efficacy in postmenopausal breast cancers, the mechanism of increasing aromatase activity in the stromal cells remains unclear. To analyze the estrogen signals and to detect the estrogen receptor (ER)-activating ability of adipose stromal cells for individual human breast cancers, we developed a new reporter cell system. To visualize the activation of ER, we first established a stable transformant, named E10, of human breast cancer MCF-7 cells by transfection with the estrogen-responsive element-green fluorescent protein (GFP) gene. E10 cells specifically express GFP when ER is activated by estrogen or by coculture with adipose stromal cells isolated from breast tumor tissues in the presence of testosterone, a substrate for aromatase. Treatment of adipose stromal cells with dexamethasone, a stimulator of aromatase gene expression, resulted in an increase in the expression of GFP in E10 cells in the coculture. Using this system, we characterized the adipose stromal cells of 67 human breast cancers and found that GFP expression levels vary among the cases, suggesting that the ability of adipose stromal cells to activate ERs is unique for individual breast cancers. High induction levels of GFP were observed more frequently in postmenopausal cases than in premenopausal cases, whereas they did not significantly correlate with the ER expression status. Aromatase inhibitors inhibited the induction of GFP expression in the coculture, but the sensitivities to the drugs varied among the individual cases. Aromatase gene expression levels in adipose stromal cells did not always correlate with their ability to induce GFP. These results suggest that this system to detect total ER activation based on the interaction with adipose stromal cells is a useful tool for analyzing local estrogen signals and for tumor-stromal interactions.
在绝经后乳腺癌中,脂肪基质细胞局部产生的雌激素会导致肿瘤生长进展。尽管雌激素合成的关键酶芳香化酶在脂肪基质细胞中高度表达,且芳香化酶抑制剂在绝经后乳腺癌中显示出更大疗效,但基质细胞中芳香化酶活性增加的机制仍不清楚。为了分析雌激素信号并检测脂肪基质细胞对个体人类乳腺癌的雌激素受体(ER)激活能力,我们开发了一种新的报告细胞系统。为了可视化ER的激活,我们首先通过转染雌激素反应元件 - 绿色荧光蛋白(GFP)基因,建立了人乳腺癌MCF - 7细胞的稳定转化体,命名为E10。当ER被雌激素激活或在睾酮(芳香化酶的底物)存在下与从乳腺肿瘤组织分离的脂肪基质细胞共培养时,E10细胞特异性表达GFP。用地塞米松(芳香化酶基因表达的刺激剂)处理脂肪基质细胞,导致共培养的E10细胞中GFP表达增加。使用该系统,我们对67例人类乳腺癌的脂肪基质细胞进行了表征,发现不同病例中GFP表达水平有所不同,这表明脂肪基质细胞激活ER的能力在个体乳腺癌中是独特的。绝经后病例中观察到高诱导水平的GFP比绝经前病例更频繁,然而它们与ER表达状态没有显著相关性。芳香化酶抑制剂抑制了共培养中GFP表达的诱导,但不同个体病例对药物的敏感性不同。脂肪基质细胞中芳香化酶基因表达水平并不总是与其诱导GFP的能力相关。这些结果表明,这个基于与脂肪基质细胞相互作用来检测总ER激活的系统,是分析局部雌激素信号和肿瘤 - 基质相互作用的有用工具。